Frenchay Hospital, to remove regional nodes as a block dissection, only when these are judged to be clinically involved with melanoma or when they remain suspiciously so for four weeks. If the nodes are abnormal at presentation of the primary tumour, then the operation is carried out contemporaneously with the wide excision of the primary. Involved nodes and primary tumour are only cleared in continuity when they are adjacent.
The groin dissection is only rarely extended proximal to the inguinal ligament. Such extension of surgery confers no advantage in terms of survival time and it is argued that if the tumour has reached that far then it is highly likely to be out of control and irrevocably disseminated. The only possible reason for super-radical removal of enlarged nodes is to reduce the total tumour mass so that the patient's limited defence mechanisms may have more chance of success. The evidence in favour of elective (prophylactic) en bloc dissection of clinically normal regional nodes is controversial, and many doubts exist as to its value and its advisability (Davis 1972) . It has an appreciable morbidity which also has to be taken into account. Distant secondary tumour: Prognostically ominous but apparently solitary distant metastases, in brain, liver, mesentery or lung, are often worth excising. Surgery can give patients two years or more of useful, enjoyable life.
Surgical Techniques
Valuable refinements of surgical technique have evolved and have been reported recently (Bodenham 1972) .
Conclusions
Most experienced clinicians agree that surgery still plays a dominant role in the treatment of malignant melanoma. Alone, it can rapidly and safely eradicate tumour in 50% of all cases presenting. Surgical repair is generally robust and durable and the discomfort and disfigurement, which may be caused by extensive skin surgery, can be considerably reduced with careful techniques. The late side-effects of surgery are few, controllable and benign.
There is evident surgical inability, however, to eradicate or maintain control over the bad tumours, which is common to all forms of treatment. When surgery fails it is usually a case of the stable door being locked after the horse has bolted; early surgery has an obvious advantage and earlier diagnosis and surgical treatment would be the greatest single advance in melanoma treatment.
It should not be overlooked that there is occasional predeliction of tumour for sites of surgical intervention, such as the skin graft donor site, when the graft is wrongly taken from the same limb as the primary, and the margin of the skin grafted defects which is the commonest site for local recurrence. A transitory immunosuppression follows surgical trauma and anesthesia, and may be a significant but small factor acting for the tumour and against the host.
Whilst stressing the established value of surgery in the treatment of malignant melanoma there are, of course, many fundamental problems still unsolved and the careful evaluation of different means to the same end cannot but be of benefit to our patients ultimately. Moreover it is fairly certain that the breakthrough in cancer therapy will not be surgical.
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The aim of this paper is to try to assess the value of radiotherapy as a curative form of treatment. The first group of patients I wish to discuss are those with malignant melanoma of the skin. Between 1943 and 1952 there were 165 patients having their prigiary treatment at the Christie Hospital, who were diagnosed as having malignant melanoma. Sixty-three patients had surgical excision and histologically proved disease, and of these, 38 survived five years. Seventy-eight patients were treated by radiation, most of them without histological confirmation, which was not obtained as the prevailing policy was to treat without biopsy any suspicious pigmented lesion. Biopsy was considered to be dangerous leading to dissemination and death. Most but not all of the survivors in this group of 49 probably had pigmented basal cell carcinoma, though experience of 6 patients who had a biopsy before radiation suggests that, as 2 survive, some of the cases without histological proof were cured of malignant melanoma. A larger group of patients seen between 1945 and 1966 with histologically proved melanoma treated by radiation, shows that 10 out of 31 survive at five years; so that approximately a third are cured. There were 16 patients whose lesions did not respond to radiation in the first period and after subsequent surgery 9 survived nine years, so that the policy of treating with radiation without biopsy did not make subsequent surgery any less successful in the nonresponders.
Malignant melanoma, in and around the orbit, seems to have a better prognosis with radiation. Even on the eyelids as Halnan reported in 1962, 3 of 5 patients with malignant melanoma of the eyelid survived five years, all being histologically proven. Lesions of the uveal tract are usually treated by removal of the eye and radiotherapy is mainly used in patients with locally residual or recurrent tumours. Thirteen such patients were reviewed by Halnan and 6 survived five years. In 9 of the patients the disease was confined to the orbit at the time of radiation and 5 survived five years; a much better result than when spread had occurred beyond the orbit.
Malignant melanoma may arise on the limbus but this is rare and not many series have been reported. Lederman (1952) reported good results with local surgery and threaded radon seeds delivering 3000-4000 R in three to four days.
Between 1945 and 1966 there were a total of 24 patients with malignant melanoma arising in the nose, sinuses, mouth and pharynx and larynx, and only one patient survives. During the same period 8 patients had a surgical excision and none survived. One further case treated since 1966 will probably survive five years and this illustrates how long it may be before complete regression takes place. This patient had a malignant melanoma of the left upper alveolus and left submandibular lymph gland. The primary was given 5500 rads in three weeks using a 4 MeV linear accelerator and the node received 5000 rads from a 300 kilovolt tube in the same time. The primary regressedwvery slowly and was completely healed twenty months after treatment. At this time, the lymph node which had regressed partially was thought to be growing again and was therefore excised. Histologically, it was invaded by malignant melanoma. The patient remains well 4j years after her initial treatment. Failure to cure in this group was often from distant metastases although in many instances the local disease was controlled. It seems to me from the results I have quoted that radiation is second best to surgery in the curative treatment of malignant melanoma of the skin, although it obviously has a place in situations where surgery is not applicable and may succeed in cure, and certainly in a good remission of symptoms. In other sites as in the uveal tract, it will produce a considerable number of cures, and should always be considered if surgery fails. In lesions of the mouth, sinuses, nose and pharynx, whilst cures may be unlikely as distant metastases are nearly always present, occasional cure results and good palliation is achieved in terms of local control.
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Endolymphatic Therapy
Endolymphatic therapy for melanoma is concerned with treatment ofmetastases in the regional lymph nodes. For effective therapy the lymph nodes in the direct lymphatic pathway from the melanoma should be infused. The nodes should contain metastases small enough to be destroyed by the isotope.
The material most commonly used for this type of treatment is 32P-Lipiodol. Apart from the
